- CAsToR’s PI Rafael Meza comments on FDA’s approval of menthol-flavored e-cigarettes on JAMA Medical News and Perspectives
- TAGS: #MentholBan
- POSTED: Mon Aug 12, 2024
At one time, the FDA’s thinking about menthol e-cigarettes seemed to be “if they’re going to ban menthol in cigarettes, it might be reasonable to have an alternative for those who want to quit smoking.” — CAsToR Principal Investigator Rafael Meza, PhD
- Read the full story at JAMA Medical News and Perspective
- In the news: “A Quarter of Smokers Quit Under Menthol Bans, Study Finds” in the New York Times, with comments from CAsToR Principal Investigator David Levy, PhD
- TAGS: #MentholBan
- POSTED: Mon Feb 26, 2024
In a study in 2021 that used a model to assess the effects of a menthol ban, David Levy, a Georgetown University oncology professor, found that it could lead to an overall reduction in smoking of about 15 percent. By 2060, the study projected, as many as 11 million years of life could be gained rather than lost to smoking-related deaths.
“These effects are delayed,” Dr. Levy said, “but nevertheless important.”
- Read the full story at NYTimes.com
- In the news: “A quarter of smokers quit within a year or two of menthol bans” on CNN, with comments from CAsToR Principal Investigator Rafael Meza, PhD
- TAGS: #MentholBan
- POSTED: Wed Feb 21, 2024
“It adds to the already very compelling evidence that banning menthol would result in fewer people smoking cigarettes and provide higher public health benefits, especially for populations that have pretty high rates of use, particularly Black Americans. There’s just more and more evidence every day that it would be a good idea to do a ban.” — Rafael Meza, PhD
- Read the full story at CNN.com
Rafael Meza, PhD
David Levy, PhD
Rafael Meza, PhD